GSK statement on avodart™ (dutasteride) for prostate cancer risk reduction

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Urology
Volume186
Issue number2
DOIs
StatePublished - Aug 1 2011

ASJC Scopus subject areas

  • Urology

Cite this